Steven Lewis

Steven Lewis

Auto-generated profile, based on publicly available information

Steven Lewis

Holy Cross Orthopedic Institute, Fort Lauderdale, FL, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2016 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
AWAngelica N. Willis
Angelica N. Willis
SDShirley E. Bradley Dean
Shirley E. Bradley Dean
JHJoe A. Habbouche
Joe A. Habbouche
BKBrian T. Kempers
Brian T. Kempers
MLMegan L. Ludwig
Megan L. Ludwig
MBMaria A. Burnatowska-Hledin
Maria A. Burnatowska-Hledin

4 October 2022 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
JGJose Rafael Garcia
Jose Rafael Garcia
DCDylan Cannon
Dylan Cannon
HRHugo Rodriguez
Hugo Rodriguez
GGGagan Grewal
Gagan Grewal
SLSteven Lewis
Steven Lewis
JLJonathan C. Levy
Jonathan C. Levy

1 December 2018 in Arthroplasty Today
Verified
Journal Article
Open access
SLSteven Lewis
Steven Lewis
SKShaun Kink
Shaun Kink
MRMichael Rahl
Michael Rahl
ANAshley Nord
Ashley Nord
JMJason Meldau
Jason Meldau
KRKarl Roberts
Karl Roberts
The purpose of the study was to assess patient adherence to an aspirin-based prophylactic deep venous thromboembolism (DVT) care management plan after total lower extremity arthroplasty. Using a cross-sectional study design, patients who underwent total hip or knee replacement surgery by a single senior surgeon were surveyed at their routine 6-week follow-up appointment regarding adherence to aspirin DVT prophylaxis. Postoperatively, patients were advised to take 325 mg of aspirin twice daily for 6 weeks to prevent DVT. Of the 101 patients surveyed, 45 underwent total hip arthroplasty while 56 underwent total knee arthroplasty. There were 48 (48%) patients who were still taking aspirin at their routine 6-week postoperative follow-up appointment and 53 (52%) patients who were not taking aspirin (nonadherent group). Of the latter, 3 (6%) never took aspirin postoperatively, 14 (26%) discontinued within 2 weeks postoperatively, and 23 (43%) did not take it any longer for half the time prescribed. In the nonadherent group, 8 patients reported that they felt they did not need the aspirin prophylaxis, 5 experienced side effects, and 10 were unsure of how long they needed to take it. There was 1 patient with a calf DVT and no episodes of pulmonary embolism. Over half of our study, patients did not finish their aspirin regimen. We suggest a consistent outline of medication duration throughout the pre/postop course and communication regarding aspirin cessation.

18 July 2023 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
AVAustin Vegas
Austin Vegas
DCDylan Cannon
Dylan Cannon
SLSteven Lewis
Steven Lewis
KMKevin L. Mekkawy
Kevin L. Mekkawy
JGJulie Glener
Julie Glener
JLJonathan C. Levy
Jonathan C. Levy

5 July 2023 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
AVAustin Vegas
Austin Vegas
DCDylan Cannon
Dylan Cannon
SLSteven Lewis
Steven Lewis
JGJulie Glener
Julie Glener
KMKevin L. Mekkawy
Kevin L. Mekkawy
JLJonathan C. Levy
Jonathan C. Levy

14 May 2022 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
DCDylan Cannon
Dylan Cannon
JGJose Garcia
Jose Garcia
AWAdam Watkins
Adam Watkins
HRHugo Rodriguez
Hugo Rodriguez
SLSteven Lewis
Steven Lewis
JLJonathan C. Levy
Jonathan C. Levy